カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の口腔乾燥症治療薬市場（2023-2030）：種類別（OTC、処方薬）、製品別（唾液分泌促進剤、唾液代用品、歯磨剤）、地域別

【英語タイトル】Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV261）・商品コード：GRV23NOV261
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

口腔乾燥症治療薬市場の成長と動向
Grand View Research, Inc.の最新レポートによると、口腔乾燥症治療薬の世界市場規模は2023年から2030年にかけて年平均成長率3.8%で拡大し、2030年には27億米ドルに達する見込みです。口腔乾燥症製品に対する有利な償還政策の増加や、関連疾患に対する意識の高まりが、市場成長に寄与する主な要因です。

また、口腔乾燥症や、シェーグレン症候群、糖尿病、高血圧、パーキンソン病などの関連疾患の有病率の増加は、市場全体にプラスの影響を与えています。コルゲート・パルモリーブ・カンパニーによると、米国では2,500万人がドライマウスを経験しています。Sjogren Syndrome Foundation of Americaによると、約400万人のアメリカ人が自己免疫疾患であるシェーグレン症候群に苦しんでいます。

口腔乾燥症や関連疾患に対する認識を高めるためのイニシアチブの高まりが、成長の原動力になると予想されます。例えば、米国シェーグレン症候群財団は、啓発プログラムを実施し、米国とカナダで同症候群に苦しむ患者を支援しています。2012年、同財団は、2017年までに同症候群の診断に要する期間を2.5年未満に短縮することを目的とした「5-Year Breakthrough Goal」を開始しました。

さらに、大手企業は新興企業の買収に注力し、ドライマウス症状に対する認識を高めるためのプログラムを実施しています。例えば、Church & Dwight Co., Inc.のブランドであるOrajelは、デジタルマーケティング代理店であるiCrossingの協力を得て、口腔ケアの重要性について親を教育するキャンペーンを開始しました。

口腔乾燥症治療薬市場レポートハイライト

- 口腔乾燥症治療薬の世界市場規模は2022年に20億米ドルと推定され、2023年から2030年までの年平均成長率は3.8%と予測されます。

- 入手のしやすさ、手頃な価格、効率の高さなどの要因から、OTCセグメントが市場を独占しています。

- 歯科用剤セグメントは予測期間中に最も速いCAGRで成長する見込みです。

- ドライマウスの原因となる疾患の有病率の増加や口腔乾燥症に関する意識向上のためのイニシアチブの高まりなどの要因により、北米が2022年に最大のシェアを占めました。

- アジア太平洋地域は、疾患に対する意識の高まりと医療費の増加により、今後10年間で有利な成長が見込まれています。

- GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Companyなどの主要企業が世界の口腔乾燥症治療薬市場を独占しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の口腔乾燥症治療薬市場：タイプ別予測・動向分析
第5章. 世界の口腔乾燥症治療薬市場：製品別予測・動向分析
第6章. 世界の口腔乾燥症治療薬市場：地域別予測・動向分析
第7章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Xerostomia Therapeutics Market Analysis Tools
3.4.1. Industry analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis
4.1. Xerostomia Therapeutics Market: Key Takeaways
4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Over-the-counter (OTC)
4.3.1. Over-the-counter (OTC) market estimates and forecast 2018 to 2030 (USD million)
4.4. Prescription
4.4.1. Prescription market estimates and forecast 2018 to 2030 (USD million)
Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis
5.1. Xerostomia Therapeutics Market: Key Takeaways
5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Salivary Stimulants
5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
5.4. Salivary Substitutes
5.4.1. Salivary substitutes market estimates and forecast 2018 to 2030 (USD Million)
5.5. Dentifrices
5.5.1. Dentifrices market estimates and forecast 2018 to 2030 (USD million)
Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. China
6.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.5.2. Japan
6.5.2.1. Market estimates and forecast, 2018 – 2030 (Volume, Thousand)
6.5.3. India
6.5.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Acacia Pharma
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Type benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Parnell Pharmaceuticals, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Type benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Pfizer, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Type benchmarking
7.2.3.4. Strategic initiatives
7.2.4. GlaxoSmithKline plc
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Type benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Church & Dwight Co., Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Type benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Lupin
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Type benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Sun Pharmaceutical Industries, Ltd.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Type benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Hikma Pharmaceuticals PLC
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Type benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Pendopharm
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Type benchmarking
7.2.9.4. Strategic initiatives
7.2.10. OraCoat
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Type benchmarking
7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 3 North America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 North America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 7 Canada xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 8 Canada xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 9 Europe xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 10 Europe xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 Europe xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 13 Germany xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 14 UK xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 15 UK xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 16 France xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 17 France xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 18 Italy xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 19 Italy xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 20 Spain xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 21 Spain xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 22 Sweden xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 24 Norway xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 25 Norway xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 26 Denmark xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 28 APAC xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 29 APAC xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 APAC xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 31 Japan xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 32 Japan xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 33 China xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 34 China xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 35 India xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 36 India xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 37 Australia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 38 Australia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 39 Thailand xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 41 South Korea xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 43 Latin America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 48 Mexico xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 50 Argentina xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 59 UAE xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 60 UAE xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 61 Kuwait xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Xerostomia therapeutics: market outlook
Fig. 9 Xerostomia therapeutics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Xerostomia therapeutics market driver impact
Fig. 15 Xerostomia therapeutics market restraint impact
Fig. 16 Xerostomia therapeutics market strategic initiatives analysis
Fig. 17 Xerostomia therapeutics market: type movement analysis
Fig. 18 Xerostomia therapeutics market: type outlook and key takeaways
Fig. 19 Over-the-counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Xerostomia therapeutics market: product movement analysis
Fig. 22 Xerostomia therapeutics market: product outlook and key takeaways
Fig. 23 Salivary stimulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Salivary substitutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Dentifrices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Xerostomia therapeutics market: material movement analysis
Fig. 27 Global xerostomia therapeutics market: regional movement analysis
Fig. 28 Global xerostomia therapeutics market: regional outlook and key takeaways
Fig. 29 North America, by country
Fig. 30 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

★調査レポート[世界の口腔乾燥症治療薬市場（2023-2030）：種類別（OTC、処方薬）、製品別（唾液分泌促進剤、唾液代用品、歯磨剤）、地域別] (コード：GRV23NOV261)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の口腔乾燥症治療薬市場（2023-2030）：種類別（OTC、処方薬）、製品別（唾液分泌促進剤、唾液代用品、歯磨剤）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の血漿タンパク質治療薬市場（2023-2030）：製品別（アルブミン、免疫グロブリン、血漿由来第VIII因子）、用途別（血友病、PID、ITP）、地域別
  • 世界のミクロトーム市場（2023-2030）：製品別（ミクロトーム装置、付属品）、技術別（全自動、手動）、地域別
  • 世界の患者ポジショニングシステム市場（2023-2030）：製品別（テーブル、付属品）、用途別（手術、診断）、用途別（病院、外来）、地域別
  • 世界のテレラジオロジーサービス市場（2023-2030）：種類別（陸上、海上）、モダリティ別（CT、超音波）、地域別
  • 世界のレジオネラ菌検査市場（2023-2030）：種類別（水質検査、IVD検査）、エンドユーザー別（微生物培養、直接蛍光抗体（DFA）染色、PCR、その他）、地域別
  • 世界の蒸気オートクレーブ市場（2023-2030）：構成別（縦型、横型）、用途別（医療、歯科）、地域別
  • 世界の医療用カート市場（2023-2030）：製品別（移動型コンピューティングカート、壁掛け型ワークステーション、薬剤）、種類別（麻酔、救急、処置）、エンドユーザー別、地域別
  • 世界の超音波ジェル市場（2023-2030）：種類別（非滅菌、滅菌）、エンドユーザー別（病院、外来センター、クリニック）、地域別
  • 世界の膣若返り市場（2023-2030）：治療種類別（再建的膣若返り、美容的膣若返り）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆